Khalid Islam - Executive Chairman, Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Khalid Islam - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Khalid Islam for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 881K $880K $1.00 Aug 9, 2024 Indirect
Common Stock 50K $49.9K $1.00 Aug 9, 2024 Direct
Stock Option (right to buy) 15K Jun 24, 2024 Direct Common Stock

Transactions reported by Khalid Islam for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.